Elevated high sensitive C-reactive protein and apelin levels after percutaneous coronary intervention and drug-eluting stent implantation

Elevated high sensitive C-reactive protein and apelin levels after percutaneous coronary intervention and drug-eluting stent implantation 1 first-author †E-mail:duxinheart@sina.comchshma@vip.sina.com †E-mail:duxinheart@sina.comchshma@vip.sina.com duxinheart@sina.com 1 1 1 2 1 corresp ‡Corresponding Author ‡Corresponding Author †E-mail:duxinheart@sina.comchshma@vip.sina.com †E-mail:duxinheart@sina.comchshma@vip.sina.com duxinheart@sina.com Cardiovascular Division, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China Cardiovascular Division, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Beijing 100083, China Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Beijing 100083, China Objective: 2 Percutaneous coronary intervention (PCI) triggers an acute inflammatory response, while sirolimus is known to have anti-inflammatory properties; the inflammatory system response to PCI after sirolimus-eluting stent placement remains unclear. The purpose of this study is to determine the changes in high sensitive C-reactive protein (hs-CRP) and apelin after PCI procedure and drug-eluting stent implantation in patients with and without reduced left ventricular systolic function. Methods: 2 Forty-eight consecutive patients undergoing PCI at the Beijing Anzhen Hospital between July and September 2006 were recruited. Sirolimus-eluting stents were employed in all patients. Blood samples were drawn immediately before and 24 h after the procedure. Plasma hs-CRP and apelin levels were determined by enzyme immunoassay. Results: 2 Paired t -test revealed a significant increase in both hs-CRP and apelin post-procedure ( P =0.006 and P < 0.0001, respectively). Patients with reduced left ventricular ejection fraction (LVEF) had significantly lower baseline apelin levels compared to those with normal ventricular function [(46.8±10.8) vs. (72.0±8.4) pg/ml, P < 0.001]. However, apelin increased to a level similar to the level of those with normal left ventricular systolic function 24 h after the PCI procedure [(86.7±11.6) vs. (85.1±6.1) pg/ml, P =0.72]. Conclusions: 2 hs-CRP and apelin levels increased after PCI and sirolimus-eluting stent implantation. Patients with impaired left ventricular systolic function had significantly lower baseline apelin levels, which increased significantly after PCI. High sensitive C-reactive protein (hs-CRP) Apelin Percutaneous coronary intervention (PCI) Introduction 1 Each year, millions of patients with coronary heart disease worldwide are treated by means of percutaneous coronary intervention (PCI). Balloon angioplasty and stent implantation can cause endothelial denudation and medial dissection. The inflammatory response to these injuries might be an important mechanism for the initiation of atherosclerosis and restenosis (Kornowski et al., 1998 1998 ). It has been previously reported that PCI triggers an acute inflammatory response leading to elevations in high sensitive C-reactive protein (hs-CRP) (Almagor et al., 2003 2003 ), which is implicated in vascular dysfunction and in the progression of atherosclerosis. Sirolimus has been demonstrated to have anti-inflammatory properties (Oberhoff et al., 2002 2002 ). Whether the inflammatory response to PCI after sirolimus-eluting stent placement is attenuated or not has not been extensively investigated and available data are conflicting (Gogo et al., 2005 2005 ; Kim et al., 2005 2005 ; Kochiadakis et al., 2007 2007 ). Although application of drug-eluting stents has dramatically reduced the incidence of restenosis after PCI, delayed healing of the traumatized vessel wall and long-term endothelial dysfunction after sirolimus-eluting stent implantation have been reported in porcine and human coronary arteries (Serry and Penny, 2005 2005 ; Togni et al., 2005 2005 ; Hofma et al., 2006 2006 ). Apelin was found recently to be the endogenous ligand of the human orphan receptor APJ (Tatemoto et al., 1998 1998 ; Szokodi et al., 2002 2002 ). The restricted presence of apelin in endothelial cells suggests that apelin may play a role as a locally secreted cardiovascular mediator of endothelium function (Kleinz and Davenport, 2004 2004 ). It has been demonstrated that apelin is decreased in patients with heart failure (Chen et al., 2003 2003 ). As an endothelium-derived substance, it is not known to what extent apelin will respond to acute coronary artery endothelium damage in PCI patients with and without heart failure. The aim of the present study was to investigate the responses of hs-CRP and apelin to PCI and sirolimus-eluting stent placement in patients with normal and abnormal ventricular function. Patients and methods 1 Study population 2 Consecutive patients with stable or unstable angina pectoris undergoing PCI at the Beijing Anzhen Hospital between July and September 2006 were prospectively recruited. All patients included in the study had a successful procedure defined as a percentage diameter of residual stenosis <50% in the worse of two orthogonal views. All subjects received clopidogrel and aspirin before the procedure. Subjects received enoxaparin 0.5 mg/(kg body weight) intra-arterially at the start of, or enoxaparin 1 mg/(kg body weight) subcutaneously within 6 h before, the procedure. Informed consent was obtained from all participants. Exclusion criteria included PCI within the last 14 d, acute ST-elevation myocardial infarction or cardiogenic shock, presence of infection or inflammatory disease, and contraindication to anticoagulation or excessive risk of bleeding. Study protocol 2 Each subject underwent a physical examination and a structured interview to elicit details of symptoms, past medical history, and medications. The following characteristics were recorded: age, sex, cardiovascular risk factors, acute treatment, and extent of coronary artery disease. Blood samples for serologic analyses were drawn at enrolment from each subject in the sitting position. A 12-lead electrocardiography (ECG) was performed at enrolment. A standardized echocardiogram including a comprehensive 2D, M-mode, and Doppler evaluation was also obtained. Reduced left ventricular ejection fraction (LVEF) was defined as LVEF<40%. Angiography and PCI were performed via the femoral approach using a standard technique. PCI consisted of balloon angioplasty and coronary stenting in all cases. Sirolimus-eluting stents were employed in all subjects. Blood samples for biomarker test were drawn immediately before angiography and 24 h after the procedure. Blood sampling and biomarker assay 2 Blood samples were obtained in ethylenediaminetetraacetic acid (EDTA)-containing tubes and centrifuged. Plasma was extracted and stored at −80 °C until analysis. Plasma apelin levels were determined using a commercially available enzyme immunoassay (Phoenix Pharmaceuticals, Belmont, CA, USA) according to the manufacturer’s instructions. This assay employed an immunoaffinity purified rabbit antibody specific for apelin (Ellinor et al., 2006 2006 ). Plasma hs-CRP levels were evaluated using a high-sensitivity enzyme-linked immunosorbent assay (ELISA). Statistical analysis 2 Normal distribution for all variables was checked using the one-sample Kolmogorov-Smirnov test. The values were expressed as mean±standard deviation (SD). Differences in the means of the continuous variables were assessed using the two-tailed Student’s t -test. Discrete variables were expressed as rates, and comparisons were tested by χ 2 analysis. Intra-individual comparison between the pre- and post-procedure continuous variables was performed with a paired t -test. A multivariate analysis was performed to determine the correlates of apelin level differences by regressing the difference of apelin levels on clinical variables. Statistical analysis was performed with SPSS 13.0 for Windows (SPSS, Chicago, Illinois, USA). Differences were considered significant with P ≤0.05. Results 1 A total of 48 patients undergoing PCI during the study period were recruited. Twenty-three subjects presented with unstable angina pectoris, and the others had stable angina. Twenty-nine subjects (60.4%) had treated hypertension whilst 11 (22.9%) had a diagnosis of diabetes mellitus. Twelve subjects (25%) had reduced LVEF. All were treated with aspirin and cardioselective β-blockers. Most were on statin treatment prior to PCI. The vessel numbers treated by PCI were 1 in 16 subjects, 2 in 18 subjects, and 3 in 14 subjects. There were no peri-procedure complications, and all had undetectable troponin T levels 24 h after revascularization. Clinical characteristics are presented in Table 1 1 . Values are expressed as mean±SD or n (%) HDL: high density lipoprotein; LVEF: left ventricular ejection fraction Variable Value * * Age (year) 63.5±10.9 Men 32 (66.7%) Hypertension 29 (60.4%) Diabetes 11 (22.9%) Current smokers 21 (43.7%) Body mass index (kg/m 2 ) 25.9±2.8 Total cholesterol (mmol/L) 4.3±0.8 HDL-cholesterol (mmol/L) 0.9±0.1 Triglycerides (mmol/L) 1.8±0.9 Creatinine (mmol/L) 70.2±17.3 Ejection fraction (%)  Patients with normal LVEF 64.3±7.6  Patients with reduced LVEF 34.8±5.1 Systolic blood pressure (mmHg) 128.6±18.7 Diastolic blood pressure (mmHg) 75.3±9.4 Medications  Aspirin 48 (100%)  β-blocker 48 (100%)  Statin 45 (93.7%)  Nitroglycerin 40 (83.3%) hs-CRP levels 2 hs-CRP increased significantly after the procedure [(1.4±0.9) vs. (4.3±3.5) mg/L, P =0.004]. Paired t -test revealed a significant elevation in hs-CRP levels after PCI compared with baseline. The mean difference between post- and pre-procedure was (2.4±3.6) mg/L, with a test statistic t value of 3.081. The two-tailed probability P value was 0.006. Apelin levels 2 Apelin increased significantly after the procedure [(68.1±13.0) vs. (86.4±10.4) pg/ml, P =0.004]. The difference between post- and pre-procedure was significant when compared by paired t -test. The mean difference was (18.4±14.5) pg/ml with a test statistic t value of 6.21 and the two-tailed probability P value < 0.0001. Fig. 1 1 shows the apelin levels in subjects with normal and reduced LVEF. Apelin levels were significantly lower at baseline in subjects with reduced LVEF [(46.8±10.8) vs. (72.0±8.4) pg/ml, P < 0.001], increasing to a level similar to that in those with normal ventricular function 24 h after the procedure [(86.7±11.6) vs. (85.1±6.1) pg/ml, P =0.72]. LVEF was the only variable that independently related to the degree of post-procedure apelin elevation ( β =−0.636, standard error (SE)=1.981, P =0.003). P < 0.001 between pre- and post-procedure for each group; P < 0.001 between baseline apelin levels; No significant difference ( P =0.72) between the two groups after the procedure Discussion 1 hs-CRP, PCI, and drug-eluting stents 2 PCI always induces a systemic inflammatory response and an elevated hs-CRP level. Whether there is a systemic inflammatory response to sirolimus-eluting stent placement is a problem not extensively evaluated to date. In the present study, we demonstrated a three-fold increase in hs-CRP levels after drug-eluting stent placement, an increase similar to reports with bare-mental stents (Gogo et al., 2005 2005 ). Apelin, PCI, and drug-eluting stents 2 Apelin, the endogenous ligand of the human orphan receptor APJ, was first isolated from the bovine stomach as a 36-amino acid peptide (Tatemoto et al., 1998 1998 ). APJ receptor, which is closely related to angiotensin II receptor (Habata et al., 1999 1999 ), is a 380-amino acid seven-trans-membrane domain Gi-coupled receptor that was originally isolated by the polymerase chain reaction (PCR) from human genomic DNA (Hosoya et al., 2000 2000 ). The biological roles of apelin are only beginning to be explored. Previous work has confirmed that apelin is a powerful vasodilator and positive inotrope and the regulation of apelin system has been studied in the pathological conditions of heart failure (Chen et al., 2003 2003 ). It has been demonstrated recently that apelin is present to a limited degree in endothelial cells, with a potent ability to stimulate the proliferation of cultured human umbilical vein endothelial cells (Masri et al., 2004 2004 ). Endothelial denudation and retarded re-endothelialization after angioplasty injury and drug-eluting stent implantation warn of the increased risk of late stent thrombosis and the impaired endothelial-dependent vasomotion (Bavry et al., 2006 2006 ). Endothelium-dependent coronary vasomotion adjacent to drug-eluting stents has been demonstrated to be impaired in practically all cases investigated thus far (Serry and Penny, 2005 2005 ; Togni et al., 2005 2005 ; Hofma et al., 2006 2006 ). As the importance of apelin in modulating normal and pathologic angiogenesis is being revealed, apelin up-regulation after angioplasty suggests that it may play a protective pathophysiologic role after endothelium injury. We made the deduction that the apelin system may facilitate the self-renewal of coronary artery epithelium and accelerate structural recovery after injury. Further study on how apelin levels correlate with re-endothelialization status and long-term prognosis is necessary. It has been demonstrated in animal experiments that apelin infusion acutely improved systolic as well as diastolic left ventricular function (Chen et al., 2003 2003 ). In fact, apelin is one of the most potent endogenous positive inotropic substances. Recently, low apelin peptide levels were found in failing human hearts, which were up-regulated after the addition of a left ventricular assist device (Chen et al., 2003 2003 ). We confirmed in the present study that apelin was reduced in subjects with impaired left ventricular function. Furthermore, our study demonstrates that, after PCI, the apelin level increased more prominently in those with reduced LVEF than in those with normal LVEF. Whether the restoration of apelin levels contributes to ventricular function improvement after the procedure of revascularization is yet to be elucidated, and this information will be useful for assessing the role of PCI in the therapy of ischemic heart failure. Apelin’s physiological effect of lowering blood pressure after intravenous injection into rats had been demonstrated. This effect could be abolished in the presence of a nitric oxide synthesis inhibitor, suggesting that apelin lowers blood pressure through a nitric oxide mechanism (Tatemoto et al., 1998 1998 ). Apelin may act as a vasorelaxing factor on coronary artery. However, this vasorelaxing effect can only be exerted in the presence of functional endothelium (Kleinz and Davenport, 2004 2004 ). In endothelium denuded isolated human saphenous veins, apelin is a potent vasoconstrictor, with a maximum response comparable to that of angiotensin II (Katugampola et al., 2001 2001 ). In the scenario of drug-eluting stent placement, endothelium is denuded and re-endothelialization is retarded. It is not clear whether apelin up-regulation could be a maladaptation that may lead to coronary vasomotion or a protective reaction that may promote endothelium regeneration. Conclusions 1 hs-CRP levels increased three-fold after PCI and sirolimus-eluting stent implantation despite the anti-inflammatory effects of sirolimus. Apelin levels increased after PCI, especially in patients with impaired left ventricular systolic function. Apelin up-regulation may be an adaptive reaction for the endothelium recovery and ventricular systolic function improvement, while it may be a maladaptation for the vasomotion in the absence of functional endothelium. The pathophysiological effects of apelin with PCI need further study. References M Almagor , A Keren , S Banai . Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease . American Heart Journal , 2003 . 145 ( 2 ): 248 - 253 . 12595841 DOI: 10.1067/mhj.2003.16 http://doi.org/10.1067/mhj.2003.16 . Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease AA Bavry , DJ Kumbhani , TJ Helton , PP Borek , GR Mood , DL Bhatt . Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials . The American Journal of Medicine , 2006 . 119 ( 12 ): 1056 - 1061 . 17145250 DOI: 10.1016/j.amjmed.2006.01.023 http://doi.org/10.1016/j.amjmed.2006.01.023 . Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials MM Chen , EA Ashley , DX Deng , A Tsalenko , A Deng , R Tabibiazar , A Ben-Dor , B Fenster , E Yang , JY King , 等 . Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction . Circulation , 2003 . 108 ( 12 ): 1432 - 1439 . 12963638 DOI: 10.1161/01.CIR.0000091235.94914.75 http://doi.org/10.1161/01.CIR.0000091235.94914.75 . Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction PT Ellinor , AF Low , CA MacRae . Reduced apelin levels in lone atrial fibrillation . European Heart Journal , 2006 . 27 ( 2 ): 222 - 226 . 16278229 DOI: 10.1093/eurheartj/ehi648 http://doi.org/10.1093/eurheartj/ehi648 . Reduced apelin levels in lone atrial fibrillation PB Gogo , DJ Schneider , MW Watkins , EF Terrien , BE Sobel , HL Dauerman . Systemic inflammation after drug-eluting stent placement . Journal of Thrombosis and Thrombolysis , 2005 . 19 ( 2 ): 87 - 92 . 16052297 DOI: 10.1007/s11239-005-1378-6 http://doi.org/10.1007/s11239-005-1378-6 . Systemic inflammation after drug-eluting stent placement Y Habata , R Fujii , M Hosoya , S Fukusumi , Y Kawamata , S Hinuma , C Kitada , N Nishizawa , S Murosaki , T Kurokawa , 等 . Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum . Biochimica et Biophysica Acta , 1999 . 1452 ( 1 ): 25 - 35 . 10525157 DOI: 10.1016/S0167-4889(99)00114-7 http://doi.org/10.1016/S0167-4889(99)00114-7 . Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum SH Hofma , WJ van der Giessen , BM van Dalen , PA Lemos , EP McFadden , G Sianos , JM Ligthart , D van Essen , PJ de Feyter , PW Serruys . Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation . European Heart Journal , 2006 . 27 ( 2 ): 166 - 170 . 16249221 DOI: 10.1093/eurheartj/ehi571 http://doi.org/10.1093/eurheartj/ehi571 . Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation M Hosoya , Y Kawamata , S Fukusumi , R Fujii , Y Habata , S Hinuma , C Kitada , S Honda , T Kurokawa , H Onda , 等 . Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin . Journal of Biological Chemistry , 2000 . 275 ( 28 ): 21061 - 21067 . 10777510 DOI: 10.1074/jbc.M908417199 http://doi.org/10.1074/jbc.M908417199 . Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin SD Katugampola , JJ Maguire , SR Matthewson , AP Davenport . [(125)I]-(Pyr(1)) apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man . British Journal of Pharmacology , 2001 . 132 ( 6 ): 1255 - 1260 . 11250876 DOI: 10.1038/sj.bjp.0703939 http://doi.org/10.1038/sj.bjp.0703939 . [(125)I]-(Pyr(1)) apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man JY Kim , YG Ko , CY Shim , S Park , KC Hwang , D Choi , Y Jang , N Hung , WH Shim , SY Cho . Comparison of effects of drug-eluting stents versus bare metal stents on plasma C-reactive protein levels . The American Journal of Cardiology , 2005 . 96 ( 10 ): 1384 - 1388 . 16275183 DOI: 10.1016/j.amjcard.2005.07.042 http://doi.org/10.1016/j.amjcard.2005.07.042 . Comparison of effects of drug-eluting stents versus bare metal stents on plasma C-reactive protein levels MJ Kleinz , AP Davenport . Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells . Regulatory Peptides , 2004 . 118 ( 3 ): 119 - 125 . 15003827 DOI: 10.1016/j.regpep.2003.11.002 http://doi.org/10.1016/j.regpep.2003.11.002 . Immunocytochemical localization of the endogenous vasoactive peptide apelin to human vascular and endocardial endothelial cells GE Kochiadakis , ME Marketou , DA Arfanakis , K Sfiridaki , EI Skalidis , NE Igoumenidis , MI Hamilos , S Kolyvaki , G Chlouverakis , E Kantidaki , 等 . Reduced systemic inflammatory response to implantation of sirolimus-eluting stents in patients with stable coronary artery disease . Atherosclerosis , 2007 . 194 ( 2 ): 433 - 438 . 16997310 DOI: 10.1016/j.atherosclerosis.2006.08.029 http://doi.org/10.1016/j.atherosclerosis.2006.08.029 . Reduced systemic inflammatory response to implantation of sirolimus-eluting stents in patients with stable coronary artery disease R Kornowski , MK Hong , FO Tio , O Bramwell , H Wu , MB Leon . In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia . Journal of the American College of Cardiology , 1998 . 31 ( 1 ): 224 - 230 . 9426044 DOI: 10.1016/S0735-1097(97)00450-6 http://doi.org/10.1016/S0735-1097(97)00450-6 . In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia B Masri , N Morin , M Cornu , B Knibiehler , Y Audigier . Apelin (65–77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells . The FASEB Journal , 2004 . 8 ( 5 ): 1909 - 1911 . DOI: 10.1096/fj.04-1930fje http://doi.org/10.1096/fj.04-1930fje . Apelin (65–77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells M Oberhoff , C Herdeg , A Baumbach , KR Karsch . Stent-based antirestenotic coatings (sirolimus/paclitaxel) . Catheterization and Cardiovascular Interventions , 2002 . 55 ( 3 ): 404 - 408 . 11870952 DOI: 10.1002/ccd.10034 http://doi.org/10.1002/ccd.10034 . Stent-based antirestenotic coatings (sirolimus/paclitaxel) R Serry , WF Penny . Endothelial dysfunction after sirolimus-eluting stent placement . Journal of the American College of Cardiology , 2005 . 46 ( 2 ): 237 - 238 . 16022948 DOI: 10.1016/j.jacc.2005.04.020 http://doi.org/10.1016/j.jacc.2005.04.020 . Endothelial dysfunction after sirolimus-eluting stent placement I Szokodi , P Tavi , G Foldes , S Voutilainen-Myllyla , M Ilves , H Tokola , J Piuhola , J Rysä , M Tóth , H Ruskoaho . Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility . Circulation Research , 2002 . 91 ( 5 ): 434 - 440 . 12215493 DOI: 10.1161/01.RES.0000033522.37861.69 http://doi.org/10.1161/01.RES.0000033522.37861.69 . Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility K Tatemoto , M Hosoya , Y Habata , R Fujii , T Kakegawa , MX Zou , Y Kawamata , S Fukusumi , S Hinuma , C Kitada , 等 . Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor . Biochemical and Biophysical Research Communications , 1998 . 251 ( 2 ): 471 - 476 . 9792798 DOI: 10.1006/bbrc.1998.9489 http://doi.org/10.1006/bbrc.1998.9489 . Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor M Togni , S Windecker , R Cocchia , P Wenaweser , S Cook , M Billinger , B Meier , OM Hess . Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction . Journal of the American College of Cardiology , 2005 . 46 ( 2 ): 231 - 236 . 16022947 DOI: 10.1016/j.jacc.2005.01.062 http://doi.org/10.1016/j.jacc.2005.01.062 . Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction 10.1631/jzus.B1001004 Project (No. QN2008-001) supported by the Beijing Municipal Health Bureau Young Persons’ Foundation, China 2010-06-17 2010-07-07 2010-07-05 2022-01-05 Copyright © Zhejiang University and Springer-Verlag Berlin Heidelberg 2010 2010 Journal of Zhejiang University-SCIENCE B (Biomedicine and Biotechnology) 08 11